Table 2 Population attributable risk (PAR) of risk factors in the original and extended cohort
RS-I | RS-II | |||||
|---|---|---|---|---|---|---|
n/N 624/7,003 | n/N 145/2,953 | |||||
HR (95 % CI) | PAR (95 % CI) per category | Combined PAR per risk factor (95 % CI) | HR (95 % CI) | PAR (95 % CI) per category | Combined PAR per risk factor (95 % CI) | |
Body mass index | NA | NA | ||||
<18.5 | 1.25 (0.62–2.56) | 0.00 (0.00–0.08) | 1.41 (0.19–10.49) | 0.00 (0.00–0.67) | ||
25–30 | 0.96 (0.81–1.15) | NA | 0.90 (0.61–1.32) | NA | ||
>30 | 0.84 (0.65–1.08) | NA | 0.81 (0.48–1.36) | NA | ||
Hypertension | 1.07 (0.89–1.27) | 0.04 (0.00–0.44) | 1.25 (0.81–1.94) | 0.16 (0.02–0.62) | ||
Diabetes mellitus | 1.31 (1.05–1.63) | 0.04 (0.01–0.09) | 1.51 (0.96–2.37) | 0.06 (0.02–0.19) | ||
Cholesterol/HDL cholesterol | 0.03 (0.00–0.73) | NA | ||||
Quartile 2 | 1.04 (0.83–1.30) | 0.01 (0.00–0.82) | 0.64 (0.39–1.04) | NA | ||
Quartile 3 | 1.08 (0.86–1.35) | 0.02 (0.00–0.30) | 0.86 (0.53–1.39) | NA | ||
Quartile 4 | 1.04 (0.83–1.32) | 0.01 (0.00–0.70) | 0.72 (0.42–1.21) | NA | ||
Lipid lowering medication | 0.64 (0.28–1.45) | NA | 1.03 (0.60–1.74) | 0.00 (0.00–1.00) | ||
Smoking | 0.07 (0.02–0.23) | NA | ||||
Former | 1.10 (0.90–1.34) | 0.03 (0.00–0.23) | 1.00 (0.68–1.48) | 0.01 (0.00–1.00) | ||
Current | 1.33 (1.04–1.71) | 0.04 (0.02–0.10) | 0.86 (0.48–1.52) | NA | ||
Educational level | 0.07 (0.00–0.90) | 0.12 (0.00–0.89) | ||||
Intermediate | 0.99 (0.68–1.45) | NA | 1.01 (0.57–1.78) | 0.00 (0.00–1.00) | ||
Low | 1.13 (0.78–1.63) | 0.08 (0.00–0.66) | 1.32 (0.73–2.36) | 0.11 (0.02–0.51) | ||
Total | 0.23 (0.05–0.62) | 0.30 (0.06–0.76) | ||||